Status:
WITHDRAWN
Sympathetic Nerve Activity in Renal Failure
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
Chronic Kidney Disease
Hypertension
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The primary purpose is to assess the role of sympathetic activation for the development and progression of chronic renal failure. Using microneurography sympathetic activity will be registered in vari...
Eligibility Criteria
Inclusion
- chronic renal failure stages I-IV
Exclusion
- pregnancy and lactation
- severe heart failure or ischemic heart disease
- patients with NYHA III-IV
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00892892
Start Date
November 1 2009
End Date
June 1 2011
Last Update
March 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Erlangen-Nuremberg, CRC, med. Clinic 4
Erlangen, Bavaria, Germany, 91054